These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin. Marion MH; Humberstone M; Grunewald R; Wimalaratna S Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927 [TBL] [Abstract][Full Text] [Related]
11. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxins in the treatment of primary focal dystonias. Truong D J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699 [TBL] [Abstract][Full Text] [Related]
13. Nurses' role in management and treatment of dystonia. Grant SA; Meager P Nurs Times; 2005 May 10-16; 101(19):50-1. PubMed ID: 15920872 [TBL] [Abstract][Full Text] [Related]
16. [The use of botulinum toxin A in the treatment of focal dystonias]. Sławek J; Duzyński W Neurol Neurochir Pol; 1997; 31(2):207-15. PubMed ID: 9380251 [TBL] [Abstract][Full Text] [Related]